The Novo Nordisk Foundation is providing $850 million to a non-profit organization to help commercialize biomedical research in Europe. This is another contribution of the institute for this purpose. The foundation announced this financial support. The goal is to support the transition of research into commercial practice. Support is intended exclusively for Europe. The sum represents a significant investment in the biomedical sector.